AAAAAA

   
Results: 1-9 |

Table of contents of journal:

Results: 9

Authors: Wallace, JL
Citation: Jl. Wallace, The arachidonic acid pathway - New molecules and enzymes, DRUG DEVELOPMENT, 2000, pp. 1-20

Authors: Tepperman, BL Whittle, BJR
Citation: Bl. Tepperman et Bjr. Whittle, Therapeutic implications of the nitric oxide pathway in gastrointestinal diseases, DRUG DEVELOPMENT, 2000, pp. 21-60

Authors: Levine, AD Fiocchi, C
Citation: Ad. Levine et C. Fiocchi, Cytokines - Opportunities for therapeutic intervention, DRUG DEVELOPMENT, 2000, pp. 61-87

Authors: Guglietta, A Veljaca, M
Citation: A. Guglietta et M. Veljaca, Peptide growth factors in gastrointestinal disorder therapeutics, DRUG DEVELOPMENT, 2000, pp. 89-112

Authors: Holzer, P
Citation: P. Holzer, Tachykinins - From basic concepts to therapeutic implications, DRUG DEVELOPMENT, 2000, pp. 113-146

Authors: D'Amato, M Makovec, F Rovati, LC
Citation: M. D'Amato et al., CCKA receptors in gastrointestinal disorders - New therapeutic implications, DRUG DEVELOPMENT, 2000, pp. 147-176

Authors: Sarna, SK Briejer, MR Schuurkes, JAJ
Citation: Sk. Sarna et al., 5-HT3/5-HT4 receptors in motility disorders - New therapeutic agents, DRUG DEVELOPMENT, 2000, pp. 177-202

Authors: Riviere, PJM Junien, JL
Citation: Pjm. Riviere et Jl. Junien, Opioid receptors: Targets for new gastrointestinal drug development, DRUG DEVELOPMENT, 2000, pp. 203-238

Authors: Coruzzi, G Poli, E Morini, G Bertaccini, G
Citation: G. Coruzzi et al., The histamine H-3 receptor - Pharmacotherapy targets in gastrointestinal disorders, DRUG DEVELOPMENT, 2000, pp. 239-267
Risultati: 1-9 |